When will Atropine Sulfate Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Atropine Sulfate Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Atropine Sulfate Injection

Brand names: Atropine Sulfate

Category: Anesthesia, Neurology, Pediatric

Unavailable 6Available 11Not specified 2

FDA status: Current, To Be Discontinued · Last FDA update: Nov 7, 2025 · First posted: Jan 1, 2012 (in shortage 14 years 9 months) · 8 manufacturers, 19 listed presentations

As of Nov 7, 2025, the FDA lists Atropine Sulfate Injection as being discontinued. Of 19 manufacturer presentations, 6 Unavailable, 11 Available, 2 Not specified.

Ask your pharmacist: which of the 8 manufacturers below can they order right now, and whether a different strength or form of Atropine Sulfate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) NDC 16729-483-03	Accord Healthcare Inc.	Unavailable	Discontinuation of the manufacture of the drug
Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) NDC 16729-484-90	Accord Healthcare Inc.	Unavailable	Discontinuation of the manufacture of the drug
Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) NDC 76329-3340-1	Amphastar Pharmaceuticals, Inc.	Available	-
Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) NDC 16729-484-45	Accord Healthcare Inc.	Available	-
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) NDC 16729-525-08	Accord Healthcare Inc.	Unavailable	Estimated recovery: mid-September 2026
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) NDC 16729-512-43	Accord Healthcare Inc.	Unavailable	Estimated recovery: TBD
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) NDC 0517-1004-25	American Regent, Inc.	Available	-
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) NDC 63323-580-20	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) NDC 70069-631-25	Somerset Therapeutics, LLC	Available	-
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) NDC 70069-481-10	Somerset Therapeutics, LLC	Available	-
Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) NDC 0641-6251-10	Hikma Pharmaceuticals USA, Inc.	Available	-
Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) NDC 16729-526-08	Accord Healthcare Inc.	Unavailable	Estimated recovery: TBD
Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) NDC 0517-1001-25	American Regent, Inc.	Available	-
Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) NDC 70069-641-25	Somerset Therapeutics, LLC	Available	-
Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" NDC 0409-4910-34	Hospira, Inc., a Pfizer Company	Not specified	Discontinuation of the manufacture of the drug
Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" NDC 0409-4911-34	Hospira, Inc., a Pfizer Company	Not specified	Discontinuation of the manufacture of the drug
Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) NDC 0409-9630-05	Hospira, Inc., a Pfizer Company	Available	-
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) NDC 0409-1630-10	Hospira, Inc., a Pfizer Company	Unavailable	Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) NDC 64253-400-91	Medefil, Inc.	Available	-

Related medications in shortage

Other Anesthesia, Neurology, Pediatric medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Atropine Sulfate Injection (FDA data as of Nov 7, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Atropine Sulfate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Atropine Sulfate Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/atropine-sulfate-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).